Feature Channels: Respiratory Diseases and Disorders

• share
• favorite_border

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce that Sumit Chanda, Ph.D., has received a $10.2 million, four-year grant from the Department of Defense to develop and advance broad-spectrum antivirals for respiratory diseases. The award aims to provide U.S. military forces and the nation with safe, effective and innovative therapies that combat multiple types of respiratory viruses.

• share
• favorite_border

Joe G. N. "Skip" Garcia, MD, an academic pulmonary physician-scientist describes a complication in COVID-19.

• share
• favorite_border

Today, the American Thoracic Society announced that GlaxoSmithKline (GSK) has awarded the Society two grants totaling $380,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency. The first grant will fund two new $50,000 grants in the ATS Research Program in COVID-19. The second grant for $280,000 will support the Society’s patient education and outreach efforts related to COVID-19.

• share
• favorite_border

COVID-19 story ideas from Johns Hopkins.

• share
• favorite_border

Many reports have included pulmonary fibrosis as a potential consequence of COVID-19. Data shows some COVID-19 patients develop scarring on the lungs – but not necessarily chronic pulmonary fibrosis or interstitial lung disease, which are characterized by progressive scarring.

• share
• favorite_border

An interprofessional simulation-based educational program helped Mount Sinai Hospital train nearly 90% of its medical ICU staff to care for patients in prone position, as part of its 2018 implementation of a new protocol related to prone position ventilation for patients with acute respiratory distress syndrome.

• share
• favorite_border

Newswise Live Expert Panel for April 30, 2020: New tech from engineers, assessing the recession

• share
• favorite_border

Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.

• share
• favorite_border

Early reports of COVID-19 symptoms and the compelling need to quickly identify treatment options and curb the growing number of critically ill patients have led to erroneous and potentially dangerous comparisons between COVID-19 and other respiratory diseases like high altitude pulmonary edema, or HAPE.

• share
• favorite_border

Researchers report evidence that the compounds in e-cigarette liquid could potentially cause the body’s tissue repair process to go haywire and lead to scarring inside the lungs.

• share
• favorite_border

While both sexes have the capacity for phenomenal athletic achievements, women on average must work harder to breathe during strenuous exercise compared to men, according to new research.

• share
• favorite_border

Ventilators have gotten a lot of attention in the ongoing fight against COVID-19. But hundreds of hospitals around the world have another, less-publicized weapon that might help some of the most desperately ill patients survive when ventilators aren’t enough. It's called ECMO.

• share
• favorite_border

O SARS-CoV-2, o vírus que causa o COVID-19, continua a se espalhar, levando a mais de 20.000 mortes em todo o mundo em menos de quatro meses. Esforços estão progredindo para desenvolver uma vacina para o COVID-19, mas é provável que isso ainda leve de 12 a 18 meses.

• share
• favorite_border

Hemidiaphragmatic paresis, or HDP, is a condition in which one side of the diaphragm is weakened, resulting in shortness of breath and reduced respiratory function. It can occur when a patient is given regional anesthesia for shoulder surgery, using the supraclavicular nerve block. Researchers are trying to determine the right amount of anesthesia to use in the supraclavicular block so that the block still works but the chances of developing HDP are low.

• share
• favorite_border

Study: with smaller clinical trials, it may be up to doctors to notice rare drug side effects

• share
• favorite_border

How individuals, and health care professionals, deal with infection from SARS-CoV-2, the virus that causes COVID-19, varies depending on the severity of the infection.

• share
• favorite_border

New guidance is available for physicians who must go through a number of steps to provide a probable diagnosis of sarcoidosis – an inflammatory disease that affects the lungs, lymph glands, and other organs.

• share
• favorite_border

• share
• favorite_border

A team of university students and engineers has developed a low-cost ventilator using off-the-shelf components that is designed to aid patients with varying degrees of lung failure.

• share
• favorite_border

The first COVID-19 patient in Texas has been enrolled in a stem cell therapy clinical trial for acute respiratory distress syndrome (ARDS) at The University of Texas Health Science Center at Houston (UTHealth).